Recommended Global Cardiology Webinars & Conferences
Asia Pacific & Middle East
Canada
Heart 2026
About Conference
Join us for the 8th World Heart Congress 2026 which is on April 15-16, 2026 in Tokyo, Japan The conference is on the theme of "Future of Cardiology: AI, Innovation, and Patient-Centered Care". This premier event bringing together leading cardiologists, researchers, healthcare professionals, and industry experts from around the globe. This congress aims to advance cardiovascular medicine through cutting-edge research, innovative technologies, and collaborative discussions.
The Heart Congress 2026 serves as a vital platform for professionals in cardiology to exchange knowledge, present research findings, and explore new advancements in heart health. Our mission is to improve patient care by fostering scientific dialogue and professional networking.
Why Attend?
- Expert-Led Sessions: Gain insights from renowned cardiologists and researchers.
- Networking Opportunities: Connect with peers, industry leaders, and academics.
- Innovative Research: Discover the latest breakthroughs in cardiovascular medicine.
- Workshops & Panel Discussions: Engage in interactive sessions on current challenges and future trends.
Who Should Attend?
-
Cardiologists
-
Researchers & Scientists
-
Cardiac Surgeons
-
Healthcare Professionals
-
Medical Students & Academics
- Industry Experts & Innovators
Session/Tracks
1. Advances in Cardiovascular Medicine
This session explores groundbreaking innovations in cardiology, including novel drug therapies, regenerative medicine, and precision cardiology. Experts will discuss the latest clinical trials, gene therapy, and advancements in personalized treatment approaches to improve patient outcomes and revolutionize cardiovascular care.
2. Heart Diseases & Risk Factors
Understanding the epidemiology, genetics, and lifestyle factors contributing to heart diseases is essential for prevention and treatment. This session covers major risk factors such as hypertension, diabetes, obesity, and smoking, along with strategies for early detection, risk assessment, and patient education to reduce cardiovascular disease burden.
3. Interventional Cardiology & Surgery
This session highlights the latest advancements in minimally invasive procedures, stent technologies, and robotic-assisted surgeries. Experts will discuss breakthroughs in transcatheter interventions, coronary artery bypass grafting (CABG), and valve replacement therapies, improving patient safety, recovery times, and long-term outcomes in cardiovascular treatments.
4. Cardiac Imaging & Diagnostics
Explore state-of-the-art imaging techniques such as echocardiography, MRI, CT angiography, and nuclear cardiology. This session delves into their role in early disease detection, treatment planning, and monitoring cardiac health, with a focus on AI-driven diagnostics and emerging imaging modalities.
5. Hypertension & Stroke Prevention
This session addresses the growing impact of hypertension as a major contributor to strokes and cardiovascular diseases. Experts will present evidence-based strategies, lifestyle modifications, pharmacological treatments, and emerging therapies aimed at effective blood pressure management and stroke risk reduction.
6. Pediatric & Geriatric Cardiology
This session covers unique cardiovascular challenges across different age groups, from congenital heart defects in children to heart failure and arrhythmias in older adults. Discussions will focus on tailored treatment approaches, advancements in pediatric interventions, and managing cardiovascular aging effectively.
7. Digital Health & AI in Cardiology
Artificial intelligence and digital health technologies are transforming cardiology. This session explores AI-driven diagnostics, wearable health monitors, telecardiology, and predictive analytics, offering insights into how digital innovations enhance patient care, early disease detection, and remote cardiovascular health management.
8. Preventive Cardiology & Rehabilitation
Focusing on proactive cardiovascular health, this session covers strategies for lifestyle modifications, rehabilitation programs, and patient education. Experts will discuss nutrition, exercise, smoking cessation, and post-cardiac event recovery plans aimed at reducing recurrence and improving long-term heart health.
9. Regenerative Medicine in Cardiology
Explore breakthroughs in stem cell therapy, tissue engineering, and gene therapy aimed at repairing heart tissues and improving patient recovery.
10. Cardiometabolic Disorders and Diabetes
Discuss the link between diabetes, metabolic syndromes, and cardiovascular diseases, focusing on prevention and treatment strategies.
11. Heart Failure and Cardiac Regeneration
Examine novel approaches in treating heart failure, including mechanical circulatory support, regenerative therapies, and personalized medicine.
Address gender-specific risks, diagnostic challenges, and treatment approaches for cardiovascular diseases in women.
13. Sports Cardiology & Exercise Medicine
Investigate the impact of physical activity on heart health, sudden cardiac arrest in athletes, and strategies for cardiac rehabilitation.
14. Emerging Therapies in Atrial Fibrillation and Arrhythmias
Learn about novel antiarrhythmic drugs, catheter ablation techniques, and wearable technologies for heart rhythm monitoring.
Market Analysis
Cardiovascular disease remains a major health challenge in Japan. Japan records a high absolute number of CVD deaths each year and has active national policies addressing non-communicable diseases making it a strategic market for clinical programmes, research collaborations, and public-health initiatives.
Large and growing medical device market. Japan’s medical devices market is substantial (tens of billions USD) and projected to grow further over the next decade, driven by an aging population, rising prevalence of heart failure and ischemic disease, and strong healthcare R&D. This creates commercial opportunity for cardiovascular devices, diagnostics, and digital health solutions. (market estimates and growth projections reported by industry analysts).
Rising prevalence of heart failure and chronic CVD care needs. Research indicates increasing heart failure prevalence and an aging patient cohort translating into demand for chronic-care models, remote monitoring, device therapy, and rehabilitation services.
Favourable timing for spring events in Tokyo. April offers pleasant spring weather and the cherry-blossom season, which enhances international attendance appeal and tourism packages for delegates. Typical April temperatures are mild (approx. 11–18°C), though mornings/evenings can be cool
Benefits of Participation
For clinicians & researchers
-
Access to latest evidence, practice-changing trial data, and clinical guidelines.
-
Skill development through hands-on workshops and live demonstrations.
-
Platform for presenting research, getting peer feedback, and increasing citation/visibility.
For industry & startups
-
Direct access to hospital decision makers, clinical champions, and procurement leads in Japan and the wider Asia region.
-
Market intelligence and partner-finding (distributors, clinical trial sites, reimbursement advisors).
-
Opportunity for product validation, pilot projects, and regulatory/market entry discussions.
For policy makers & public-health stakeholders
-
Exchange of strategies for national CVD control, prevention programmes, and population screening approaches.
-
Visibility for national action plans and potential to co-design regional initiatives.
For all delegates
-
Networking: structured meetings, investor/partner lounges, and satellite industry sessions.
-
Cultural experience: attend during sakura season attractive for accompanying persons and boosts overall delegate satisfaction.
To Collaborate Scientific Professionals around the World
Conference Date April 15-16, 2026
For Sponsors & Exhibitors
Speaker Opportunity
Useful Links
Past Conference Report
Supported By
All accepted abstracts will be published in respective Conference Series International Journals.
Abstracts will be provided with Digital Object Identifier by